Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 237

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial

Mazighi, Mikael, Richard, Sebastien, Lapergue, Bertrand, Sibon, Igor, Gory, Benjamin, Berge, Jerome, Consoli, Arturo, Labreuche, Julien, Olivot, Jean-Marc, Broderick, Joseph, Duhamel, Alain, Touze, Emmanuel, Qureshi, Adnan I, Yavchitz, Amélie, Escalard, Simon, Desilles, Jean-Philippe, Redjem, Hocine, Smajda, Stanislas, Fahed, Robert, Hébert, Solène, Maïer, Benjamin, Delvoye, François, Boursin, Perrine, Maacha, Malek Ben, Obadia, Michael, Sabben, Candice, Blanc, Raphael, Savatovsky, Julien, Piotin, Michel, Mazighi, Mikael, Piotin, Michel, Blanc, Raphael, Redjem, Hocine, Maïer, Benjamin, Desilles, Jean-Philippe, Escalard, Simon, Smajda, Stanislas, Delvoye, François, Hebert, Solène, Obadia, Michael, Sabben, Candice, Obadia, Alexandre, Raynouard, Igor, Morvan, Erwan, Boursin, Perrine, Ben Maacha, Malek, Lapergue, Bertrand, Consoli, Arturo, Wang, Adrien, Gory, Benjamin, Richard, Sebastien, Mione, Gioia, Humbertjean, Lisa, Bonnerot, Matthieu, Lacour, Jean-Christophe, Anxionnat, René, Tonnelet, Romain, Bracard, Serge, Barreau, Xavier, Marnat, Gaultier, Berge, Jérôme, Lucas, Ludovic, Renou, Pauline, Debruxelles, Sabrina, Poli, Mathilde, Sagnier, Sharmila·2021·The Lancet Neurology

Abstract

BACKGROUND High systolic blood pressure after successful endovascular therapy for acute ischaemic stroke is associated with increased risk of intraparenchymal haemorrhage. However, no randomised controlled trials are available to guide optimal management. We therefore aimed to assess whether an intensive systolic blood pressure target resulted in reduced rates of intraparenchymal haemorrhage compared with a standard systolic blood pressure target. METHODS We did a multicentre, open-label, randomised controlled trial at four academic hospital centres in France. Eligible individuals were adults (aged ≥18 years) with an acute ischaemic stroke due to a large-vessel occlusion that was successfully treated with endovascular therapy. Patients were randomly assigned (1:1) to either an intensive systolic blood pressure target group (100-129 mm Hg) or a standard care systolic blood pressure target group (130-185 mm Hg), by means of a central web-based procedure, stratified by centre and intravenous thrombolysis use before endovascular therapy. In both groups, the target systolic blood pressure had to be achieved within 1 h after randomisation and maintained for 24 h with intravenous blood pressure lowering treatments. The primary outcome was the rate of radiographic intraparenchymal haemorrhage at 24-36 h and the primary safety outcome was the occurrence of hypotension. Analyses were done on an intention-to-treat basis. BP-TARGET is registered with ClinicalTrials.gov, number NCT03160677, and the trial is closed at all participating sites. FINDINGS Between June 21, 2017, and Sept 27, 2019, 324 patients were enrolled in the four participating stroke centres: 162 patients were randomly assigned to the intensive target group and 162 to the standard target group. Four (2%) of 162 patients were excluded from the intensive target group and two (1%) of 162 from the standard target group for withdrawal of consent or legal reasons. The mean systolic blood pressure during the first 24 h after reperfusion was 128 mm Hg (SD 11) in the intensive target group and 138 mm Hg (17) in the standard target group. The primary outcome was observed in 65 (42%) of 154 patients in the intensive target group and 68 (43%) of 157 in the standard target group on brain CT within 24-36 h after reperfusion] (adjusted odds ratio 0·96, 95% CI 0·60-1·51; p=0·84). Hypotensive events were not significantly different between both groups and occurred in 12 (8%) of 158 patients in the intensive target and five (3%) of 160 in the standard target group. Mortality within the first week after randomisation occurred in 11 (7%) of 158 patients in the intensive target group and in seven (4%) of 160 in the standard target group. INTERPRETATION An intensive systolic blood pressure target of 100-129 mm Hg after successful endovascular therapy did not reduce radiographic intraparenchymal haemorrhage rates at 24-36 h as compared with a standard care systolic blood pressure target of 130-185 mm Hg. Notably, these results are applicable to patients with successful reperfusion and systolic blood pressures of more than 130 mm Hg at the end of procedure. Further studies are needed to understand the association between blood pressure and outcomes after reperfusion. FUNDING French Health Ministry.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(20)30483-x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 237

Metadata

Authors
Mazighi, M., Richard, S., Lapergue, B., Sibon, I., Gory, B., Berge, J., Consoli, A., Labreuche, J., Olivot, J.-M., Broderick, J., Duhamel, A., Touze, E., Qureshi, A. I., Yavchitz, A., Escalard, S., Desilles, J.-P., Redjem, H., Smajda, S., Fahed, R., Hébert, S., Maïer, B., Delvoye, F., Boursin, P., Maacha, M. B., Obadia, M., Sabben, C., Blanc, R., Savatovsky, J., Piotin, M., Mazighi, M., Piotin, M., Blanc, R., Redjem, H., Maïer, B., Desilles, J.-P., Escalard, S., Smajda, S., Delvoye, F., Hebert, S., Obadia, M., Sabben, C., Obadia, A., Raynouard, I., Morvan, E., Boursin, P., Ben Maacha, M., Lapergue, B., Consoli, A., Wang, A., Gory, B., Richard, S., Mione, G., Humbertjean, L., Bonnerot, M., Lacour, J.-C., Anxionnat, R., Tonnelet, R., Bracard, S., Barreau, X., Marnat, G., Berge, J., Lucas, L., Renou, P., Debruxelles, S., Poli, M., & Sagnier, S.
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2021-04
Volume
20
Issue
4
Pages
265-274
ISSN
1474-4422 (ISSN-L)
OpenAlex
W3133993978
Cited by
237
References
2
FWCI
23.90
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial. https://app.cochat.ai/papers/10.1016/s1474-4422(20)30483-x
The paper
Mazighi, M., Richard, S., Lapergue, B., Sibon, I., Gory, B., Berge, J., Consoli, A., Labreuche, J., Olivot, J.-M., Broderick, J., Duhamel, A., Touze, E., Qureshi, A. I., Yavchitz, A., Escalard, S., Desilles, J.-P., Redjem, H., Smajda, S., Fahed, R., . . . Sagnier, S. (2021). Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(20)30483-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.